

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation (GO:0006956) | 8.23411341 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.69970554 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.62878665 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.37751097 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 6.06250142 |
| 6 | protein activation cascade (GO:0072376) | 5.97943680 |
| 7 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.40559274 |
| 8 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.40559274 |
| 9 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.40559274 |
| 10 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.39348827 |
| 11 | glomerular filtration (GO:0003094) | 5.13307660 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.77745228 |
| 13 | humoral immune response (GO:0006959) | 4.76733152 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64887116 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.64887116 |
| 16 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.56459432 |
| 17 | renal filtration (GO:0097205) | 4.54403298 |
| 18 | detection of bacterium (GO:0016045) | 4.53092601 |
| 19 | detection of other organism (GO:0098543) | 4.49520472 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.35650897 |
| 21 | germinal center formation (GO:0002467) | 4.30667791 |
| 22 | regulation of respiratory burst (GO:0060263) | 4.30167979 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25653132 |
| 24 | regulation of antigen processing and presentation (GO:0002577) | 4.08404676 |
| 25 | cellular response to type I interferon (GO:0071357) | 4.08390033 |
| 26 | type I interferon signaling pathway (GO:0060337) | 4.08390033 |
| 27 | positive regulation of antigen processing and presentation (GO:0002579) | 4.04031645 |
| 28 | response to type I interferon (GO:0034340) | 4.03758748 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.01728109 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.01090050 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.91183144 |
| 32 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.84744425 |
| 33 | regulation of cellular extravasation (GO:0002691) | 3.71854990 |
| 34 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.65423560 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56846763 |
| 36 | antimicrobial humoral response (GO:0019730) | 3.52610891 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.52127496 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.51678658 |
| 39 | retina homeostasis (GO:0001895) | 3.48756191 |
| 40 | antibacterial humoral response (GO:0019731) | 3.46827784 |
| 41 | dendritic cell chemotaxis (GO:0002407) | 3.46337364 |
| 42 | B cell mediated immunity (GO:0019724) | 3.37793059 |
| 43 | respiratory burst (GO:0045730) | 3.37631945 |
| 44 | chronic inflammatory response (GO:0002544) | 3.30277465 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 3.15421354 |
| 46 | cellular extravasation (GO:0045123) | 3.12920904 |
| 47 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10556181 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10282534 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.08601589 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08601589 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08601589 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08601589 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 3.08601589 |
| 54 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08601589 |
| 55 | macrophage activation involved in immune response (GO:0002281) | 3.08192112 |
| 56 | cellular response to interferon-gamma (GO:0071346) | 3.07800225 |
| 57 | response to interleukin-15 (GO:0070672) | 3.06951393 |
| 58 | dendritic cell migration (GO:0036336) | 3.06927802 |
| 59 | response to interferon-beta (GO:0035456) | 3.05499892 |
| 60 | defense response to protozoan (GO:0042832) | 3.03851000 |
| 61 | immune response-activating signal transduction (GO:0002757) | 3.03228955 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.01923728 |
| 63 | interferon-gamma secretion (GO:0072643) | 2.97820944 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.97318865 |
| 65 | detection of biotic stimulus (GO:0009595) | 2.95647849 |
| 66 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94605409 |
| 67 | response to interferon-gamma (GO:0034341) | 2.94247642 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 2.92749318 |
| 69 | activation of immune response (GO:0002253) | 2.91755628 |
| 70 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.91425568 |
| 71 | positive regulation of type 2 immune response (GO:0002830) | 2.90984745 |
| 72 | leukocyte aggregation (GO:0070486) | 2.88528175 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.87119388 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.87030801 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.86365831 |
| 76 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82284812 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82284812 |
| 78 | negative regulation of myotube differentiation (GO:0010832) | 2.78990176 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.78694617 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 2.78078407 |
| 81 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.78060157 |
| 82 | production of molecular mediator of immune response (GO:0002440) | 2.74726801 |
| 83 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74675179 |
| 84 | negative regulation of interleukin-12 production (GO:0032695) | 2.72704374 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.71519690 |
| 86 | negative regulation of innate immune response (GO:0045824) | 2.67590756 |
| 87 | myeloid dendritic cell activation (GO:0001773) | 2.67375538 |
| 88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67330968 |
| 89 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63835570 |
| 90 | lymphocyte chemotaxis (GO:0048247) | 2.61054786 |
| 91 | positive regulation of B cell differentiation (GO:0045579) | 2.60626569 |
| 92 | response to interferon-alpha (GO:0035455) | 2.60243359 |
| 93 | regulation of integrin activation (GO:0033623) | 2.55638807 |
| 94 | negative regulation of humoral immune response (GO:0002921) | 2.55404463 |
| 95 | T cell costimulation (GO:0031295) | 2.54595951 |
| 96 | neutrophil activation (GO:0042119) | 2.54069205 |
| 97 | negative regulation of complement activation (GO:0045916) | 2.52099035 |
| 98 | response to protozoan (GO:0001562) | 2.51684059 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50974968 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.2313909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.03293253 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.73304391 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.82007876 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.73018543 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.81257973 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.30772347 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.27722692 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.91472852 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89780032 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84826014 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63453387 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62071055 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54697122 |
| 14 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.47704805 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.40824690 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35240563 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27367424 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17995516 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.13430711 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10445202 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04451129 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00267774 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95729672 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.95066986 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94556581 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.90577180 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88259776 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86343711 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.76073943 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72313598 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66538384 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.66502134 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59980278 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55861289 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55150032 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53466503 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51104592 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50458704 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50435225 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49835607 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49668476 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48245788 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48040231 |
| 44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40654528 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40189407 |
| 46 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30063973 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30011534 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27455717 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26334541 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25033789 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21467461 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21305669 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20202898 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19851653 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19427791 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17929824 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15508375 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12385664 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11297655 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08418371 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.08356416 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08231727 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07901919 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06129785 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03938196 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03734680 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02827373 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99645496 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99083898 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98949706 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98760941 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98666793 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98484754 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97494874 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95456466 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94809705 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92756493 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90851208 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89508479 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88419278 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87633131 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86571125 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86209233 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85220326 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84534338 |
| 86 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83945800 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81985633 |
| 88 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81077213 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80666207 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80189381 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79949254 |
| 92 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79222402 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.76435108 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76108295 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75456161 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74862926 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74122645 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72720644 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72594143 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72171702 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.82255789 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.10345999 |
| 3 | MP0003303_peritoneal_inflammation | 3.84905559 |
| 4 | MP0003436_decreased_susceptibility_to | 3.62646545 |
| 5 | MP0001790_abnormal_immune_system | 3.28675302 |
| 6 | MP0005387_immune_system_phenotype | 3.28675302 |
| 7 | MP0001800_abnormal_humoral_immune | 3.20864573 |
| 8 | MP0005025_abnormal_response_to | 2.83660716 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.77657909 |
| 10 | MP0000685_abnormal_immune_system | 2.72629696 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.65487450 |
| 12 | MP0009785_altered_susceptibility_to | 2.60236542 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.59983207 |
| 14 | MP0005671_abnormal_response_to | 2.55872028 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.55691530 |
| 16 | MP0002723_abnormal_immune_serum | 2.42338181 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.38212598 |
| 18 | MP0002419_abnormal_innate_immunity | 2.36845769 |
| 19 | MP0001819_abnormal_immune_cell | 2.36797949 |
| 20 | MP0000465_gastrointestinal_hemorrhage | 2.24654589 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.13434958 |
| 22 | MP0001873_stomach_inflammation | 2.11389843 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.09739165 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.06313591 |
| 25 | MP0005166_decreased_susceptibility_to | 2.03383374 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.00886437 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.86081036 |
| 28 | MP0003866_abnormal_defecation | 1.81352340 |
| 29 | MP0000716_abnormal_immune_system | 1.76206501 |
| 30 | MP0004947_skin_inflammation | 1.75622644 |
| 31 | MP0002398_abnormal_bone_marrow | 1.75423546 |
| 32 | MP0006082_CNS_inflammation | 1.75408707 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.71233836 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.70793893 |
| 35 | MP0001986_abnormal_taste_sensitivity | 1.69203264 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.66553862 |
| 37 | MP0002405_respiratory_system_inflammati | 1.63245556 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.59550977 |
| 39 | MP0005310_abnormal_salivary_gland | 1.58812638 |
| 40 | MP0008004_abnormal_stomach_pH | 1.45617818 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.44062075 |
| 42 | MP0001663_abnormal_digestive_system | 1.41260505 |
| 43 | MP0005275_abnormal_skin_tensile | 1.40830337 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.40322589 |
| 45 | MP0002429_abnormal_blood_cell | 1.37994975 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.37136516 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.34823234 |
| 48 | MP0003075_altered_response_to | 1.28579447 |
| 49 | MP0000858_altered_metastatic_potential | 1.26231670 |
| 50 | MP0002722_abnormal_immune_system | 1.26186657 |
| 51 | MP0003448_altered_tumor_morphology | 1.24905055 |
| 52 | MP0002006_tumorigenesis | 1.21529504 |
| 53 | MP0005023_abnormal_wound_healing | 1.20658461 |
| 54 | MP0009764_decreased_sensitivity_to | 1.20374640 |
| 55 | MP0008469_abnormal_protein_level | 1.20019264 |
| 56 | MP0000343_altered_response_to | 1.16936050 |
| 57 | MP0002933_joint_inflammation | 1.16409964 |
| 58 | MP0003279_aneurysm | 1.12203521 |
| 59 | MP0001851_eye_inflammation | 1.11935873 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.07522351 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.06228545 |
| 62 | MP0005390_skeleton_phenotype | 1.06115020 |
| 63 | MP0005164_abnormal_response_to | 1.00904200 |
| 64 | MP0003045_fibrosis | 0.98585397 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 0.95000852 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 0.94903293 |
| 67 | MP0000703_abnormal_thymus_morphology | 0.93269424 |
| 68 | MP0000604_amyloidosis | 0.92685886 |
| 69 | MP0003828_pulmonary_edema | 0.92466480 |
| 70 | MP0000490_abnormal_crypts_of | 0.92222974 |
| 71 | MP0002396_abnormal_hematopoietic_system | 0.90264164 |
| 72 | MP0003183_abnormal_peptide_metabolism | 0.89954415 |
| 73 | MP0000249_abnormal_blood_vessel | 0.88781242 |
| 74 | MP0004858_abnormal_nervous_system | 0.86603487 |
| 75 | MP0009840_abnormal_foam_cell | 0.86317923 |
| 76 | MP0009278_abnormal_bone_marrow | 0.82474281 |
| 77 | MP0005503_abnormal_tendon_morphology | 0.82053469 |
| 78 | MP0003091_abnormal_cell_migration | 0.81797426 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.80618836 |
| 80 | MP0002796_impaired_skin_barrier | 0.79944921 |
| 81 | MP0002132_abnormal_respiratory_system | 0.79440112 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.78196564 |
| 83 | MP0008874_decreased_physiological_sensi | 0.77902578 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.75544200 |
| 85 | MP0001853_heart_inflammation | 0.73950034 |
| 86 | MP0002133_abnormal_respiratory_system | 0.72584805 |
| 87 | MP0005388_respiratory_system_phenotype | 0.72584805 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.69573965 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.69433829 |
| 90 | MP0004510_myositis | 0.67506131 |
| 91 | MP0003795_abnormal_bone_structure | 0.67357126 |
| 92 | MP0003868_abnormal_feces_composition | 0.60610415 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.60534123 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.60534123 |
| 95 | MP0002254_reproductive_system_inflammat | 0.60258644 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.57600900 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.57105473 |
| 98 | MP0009763_increased_sensitivity_to | 0.56257271 |
| 99 | MP0003329_amyloid_beta_deposits | 0.55901288 |
| 100 | MP0005365_abnormal_bile_salt | 0.55539822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 8.23029323 |
| 2 | Abnormality of macrophages (HP:0004311) | 6.63001206 |
| 3 | Abnormality of the prostate (HP:0008775) | 5.77809841 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.80960481 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.79943621 |
| 6 | Vasculitis (HP:0002633) | 4.68904149 |
| 7 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.02684396 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.95020498 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.93860660 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.91553747 |
| 11 | Leukocytosis (HP:0001974) | 3.81997745 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.77578966 |
| 13 | Gastrointestinal stroma tumor (HP:0100723) | 3.65981049 |
| 14 | Abnormality of male internal genitalia (HP:0000022) | 3.63924582 |
| 15 | Meningitis (HP:0001287) | 3.63298128 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57681964 |
| 17 | Increased IgE level (HP:0003212) | 3.53014395 |
| 18 | Colitis (HP:0002583) | 3.46652725 |
| 19 | Myositis (HP:0100614) | 3.44825767 |
| 20 | Skin rash (HP:0000988) | 3.34525088 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.32335944 |
| 22 | Chronic otitis media (HP:0000389) | 3.28163440 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.27426238 |
| 24 | Orchitis (HP:0100796) | 3.27146694 |
| 25 | Malnutrition (HP:0004395) | 3.24915156 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 3.23405491 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.22448420 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10023490 |
| 29 | Premature loss of primary teeth (HP:0006323) | 3.09272610 |
| 30 | Cellulitis (HP:0100658) | 3.09243070 |
| 31 | Osteomyelitis (HP:0002754) | 3.08770265 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 3.04005755 |
| 33 | Abnormality of complement system (HP:0005339) | 3.03149941 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03100084 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.97671167 |
| 36 | Obstructive lung disease (HP:0006536) | 2.97671167 |
| 37 | Urticaria (HP:0001025) | 2.93151512 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.92879858 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.92010363 |
| 40 | Optic neuritis (HP:0100653) | 2.92010363 |
| 41 | Recurrent skin infections (HP:0001581) | 2.91933193 |
| 42 | Neoplasm of the lung (HP:0100526) | 2.90486052 |
| 43 | Recurrent viral infections (HP:0004429) | 2.83733545 |
| 44 | Gingivitis (HP:0000230) | 2.77873679 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.77076240 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.77076240 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.76764143 |
| 48 | Hemoptysis (HP:0002105) | 2.74558044 |
| 49 | Complement deficiency (HP:0004431) | 2.73339223 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.69522213 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.68821647 |
| 52 | Glomerulonephritis (HP:0000099) | 2.65843458 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.59575986 |
| 54 | Pustule (HP:0200039) | 2.56718730 |
| 55 | Encephalitis (HP:0002383) | 2.56520621 |
| 56 | Neoplasm of the respiratory system (HP:0100606) | 2.56363960 |
| 57 | Emphysema (HP:0002097) | 2.55765821 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.51212203 |
| 59 | Increased IgM level (HP:0003496) | 2.49311785 |
| 60 | Chest pain (HP:0100749) | 2.46346399 |
| 61 | Hypermelanotic macule (HP:0001034) | 2.42833362 |
| 62 | Hypergammaglobulinemia (HP:0010702) | 2.41544884 |
| 63 | Abnormality of the peritoneum (HP:0002585) | 2.40597162 |
| 64 | Bronchitis (HP:0012387) | 2.34975425 |
| 65 | Lymphopenia (HP:0001888) | 2.34716084 |
| 66 | Nephritis (HP:0000123) | 2.32995687 |
| 67 | Hematochezia (HP:0002573) | 2.31271867 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.30466673 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.30128191 |
| 70 | Chronic diarrhea (HP:0002028) | 2.29654923 |
| 71 | Restrictive lung disease (HP:0002091) | 2.28513540 |
| 72 | Nasal polyposis (HP:0100582) | 2.26651058 |
| 73 | Sepsis (HP:0100806) | 2.23894247 |
| 74 | Keratoconjunctivitis (HP:0001096) | 2.23004217 |
| 75 | Verrucae (HP:0200043) | 2.21474085 |
| 76 | Papilloma (HP:0012740) | 2.21474085 |
| 77 | Gingival bleeding (HP:0000225) | 2.16728227 |
| 78 | Chronic sinusitis (HP:0011109) | 2.15808669 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.14260806 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.10995212 |
| 81 | T lymphocytopenia (HP:0005403) | 2.10525234 |
| 82 | Skin ulcer (HP:0200042) | 2.10191302 |
| 83 | Abnormality of T cells (HP:0002843) | 2.09152770 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.07971935 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.07279500 |
| 86 | Hypochromic anemia (HP:0001931) | 2.04504347 |
| 87 | IgM deficiency (HP:0002850) | 2.04453195 |
| 88 | Stomatitis (HP:0010280) | 2.02964568 |
| 89 | Prolonged bleeding time (HP:0003010) | 2.02486804 |
| 90 | Epistaxis (HP:0000421) | 2.02413135 |
| 91 | Recurrent pneumonia (HP:0006532) | 2.00706614 |
| 92 | Pulmonary embolism (HP:0002204) | 2.00416193 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.99139097 |
| 94 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95477362 |
| 95 | Villous atrophy (HP:0011473) | 1.95477362 |
| 96 | Microcytic anemia (HP:0001935) | 1.93629173 |
| 97 | Gangrene (HP:0100758) | 1.93395045 |
| 98 | Granulocytopenia (HP:0001913) | 1.93387968 |
| 99 | Purpura (HP:0000979) | 1.92065872 |
| 100 | B lymphocytopenia (HP:0010976) | 1.91862764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.41055761 |
| 2 | MAP4K1 | 4.10834620 |
| 3 | TYK2 | 3.54883512 |
| 4 | BLK | 3.27162913 |
| 5 | RIPK4 | 3.07685562 |
| 6 | BMPR2 | 2.33808969 |
| 7 | JAK3 | 2.29949509 |
| 8 | IRAK4 | 2.25228848 |
| 9 | PRPF4B | 2.20876993 |
| 10 | TXK | 2.20353176 |
| 11 | FES | 2.20289116 |
| 12 | JAK1 | 2.06365553 |
| 13 | FGFR4 | 1.99765868 |
| 14 | GRK6 | 1.99372366 |
| 15 | MST1R | 1.97982758 |
| 16 | IKBKE | 1.94482170 |
| 17 | KIT | 1.90530231 |
| 18 | CSK | 1.87189659 |
| 19 | ZAP70 | 1.82985654 |
| 20 | EPHB1 | 1.67804304 |
| 21 | SYK | 1.64615623 |
| 22 | ACVR1B | 1.63981433 |
| 23 | LYN | 1.57650478 |
| 24 | EPHA3 | 1.54221838 |
| 25 | MAP2K3 | 1.49995049 |
| 26 | CDC42BPA | 1.47164479 |
| 27 | BTK | 1.43865026 |
| 28 | JAK2 | 1.43711898 |
| 29 | MAP3K10 | 1.38477760 |
| 30 | RIPK1 | 1.33582969 |
| 31 | HCK | 1.32725828 |
| 32 | MAP3K3 | 1.32185352 |
| 33 | MAP3K14 | 1.31381204 |
| 34 | PIK3CA | 1.28454914 |
| 35 | SIK3 | 1.28135093 |
| 36 | CSF1R | 1.27876898 |
| 37 | TBK1 | 1.26027598 |
| 38 | IRAK1 | 1.22448142 |
| 39 | MAP3K1 | 1.22264320 |
| 40 | FGFR3 | 1.21568397 |
| 41 | ITK | 1.19685425 |
| 42 | IKBKB | 1.17821037 |
| 43 | TEC | 1.12633010 |
| 44 | MST4 | 1.11322171 |
| 45 | MAP3K13 | 1.01709104 |
| 46 | TNK2 | 1.01385857 |
| 47 | TAOK1 | 1.00405513 |
| 48 | LCK | 0.96670441 |
| 49 | MATK | 0.92217127 |
| 50 | NLK | 0.91877433 |
| 51 | FGR | 0.90411620 |
| 52 | HIPK2 | 0.88399659 |
| 53 | TAOK3 | 0.85954686 |
| 54 | STK39 | 0.80875459 |
| 55 | SMG1 | 0.78430681 |
| 56 | EIF2AK3 | 0.78383045 |
| 57 | YES1 | 0.77172170 |
| 58 | OXSR1 | 0.76155691 |
| 59 | PKN2 | 0.71407807 |
| 60 | TGFBR2 | 0.70554027 |
| 61 | FER | 0.68019097 |
| 62 | LRRK2 | 0.67570075 |
| 63 | KSR2 | 0.66552641 |
| 64 | PDK1 | 0.66398992 |
| 65 | FYN | 0.63344087 |
| 66 | STK24 | 0.62518425 |
| 67 | PDPK1 | 0.62122122 |
| 68 | MAPK11 | 0.58541749 |
| 69 | MAPK7 | 0.57484243 |
| 70 | MAP3K2 | 0.55799124 |
| 71 | EPHA2 | 0.53713854 |
| 72 | PTK6 | 0.53650195 |
| 73 | MARK3 | 0.53274772 |
| 74 | ABL1 | 0.50291677 |
| 75 | TRIB3 | 0.49518394 |
| 76 | NEK9 | 0.48541178 |
| 77 | STK10 | 0.47603951 |
| 78 | TAOK2 | 0.47072826 |
| 79 | PDGFRA | 0.45455805 |
| 80 | RET | 0.43527159 |
| 81 | MAP3K11 | 0.43317595 |
| 82 | PRKCQ | 0.42920445 |
| 83 | GRK5 | 0.42618929 |
| 84 | PDGFRB | 0.42103333 |
| 85 | ALK | 0.40417050 |
| 86 | PRKG2 | 0.39831346 |
| 87 | PIK3CG | 0.38568861 |
| 88 | EPHB2 | 0.37642733 |
| 89 | PIM1 | 0.36925454 |
| 90 | IRAK2 | 0.36906564 |
| 91 | CDK6 | 0.36902100 |
| 92 | MAPK12 | 0.36353159 |
| 93 | BMX | 0.35428054 |
| 94 | PRKD2 | 0.35142366 |
| 95 | IRAK3 | 0.34912528 |
| 96 | RPS6KA4 | 0.33686527 |
| 97 | MAP2K6 | 0.33094861 |
| 98 | TESK2 | 0.32464171 |
| 99 | MAPKAPK2 | 0.32360674 |
| 100 | MET | 0.31302981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.01460175 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.53713711 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.38148321 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.31424595 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.21484410 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.85896080 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82339461 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.55705753 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54679178 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45367674 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40548490 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11486021 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.08265543 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07841339 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96562904 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.80599487 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72401116 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.66028637 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.65842520 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.65216203 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64664165 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47977481 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41940916 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39381411 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37922819 |
| 26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32555842 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.30463920 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.26071655 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25934662 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25009048 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20172395 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18018737 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17454024 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16404792 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12826164 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10448399 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08287433 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.07659383 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04005372 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02615815 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02277690 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96181331 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89891560 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.83358513 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78571904 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74101645 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73958838 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71886424 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.69614417 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69535587 |
| 51 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69324555 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67816134 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.63422598 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63063039 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.61353331 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61119387 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.60283635 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59369380 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57957437 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.54876208 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52367674 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52142758 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51239066 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51117255 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50972909 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49824693 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49505487 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48978785 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.48717805 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48642199 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48317667 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48026216 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.46982969 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45050047 |
| 75 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43313120 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.40189799 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39588539 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38984462 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38463182 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38173719 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37477528 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36489567 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35981544 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35850742 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33973066 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32886322 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31508446 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30968488 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30838907 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30454205 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29785400 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27585608 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27549273 |
| 94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26966878 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26194800 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25090494 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24748280 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24703651 |
| 99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24011069 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23934171 |

